| Recurrent SETBP1 mutations in atypical chronic myeloid leukemia R Piazza, S Valletta, N Winkelmann, S Redaelli, R Spinelli, A Pirola, ... Nature genetics 45 (1), 18-24, 2013 | 423 | 2013 |
| Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia P Theunissen, E Mejstrikova, L Sedek, AJ van der Sluijs-Gelling, G Gaipa, ... Blood, The Journal of the American Society of Hematology 129 (3), 347-357, 2017 | 396 | 2017 |
| Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow G Basso, M Veltroni, MG Valsecchi, MN Dworzak, R Ratei, D Silvestri, ... Journal of clinical oncology 27 (31), 5168-5174, 2009 | 382 | 2009 |
| Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL P Lucio, A Parreira, MWM Van den Beemd, EG Van Lochem, ... Leukemia 13 (3), 419-427, 1999 | 340 | 1999 |
| Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients M Introna, G Lucchini, E Dander, S Galimberti, A Rovelli, A Balduzzi, ... Biology of blood and marrow transplantation 20 (3), 375-381, 2014 | 270 | 2014 |
| Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study M Introna, G Borleri, E Conti, M Franceschetti, AM Barbui, R Broady, ... haematologica 92 (7), 952-959, 2007 | 268 | 2007 |
| Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population G Lucchini, M Introna, E Dander, A Rovelli, A Balduzzi, S Bonanomi, ... Biology of blood and marrow transplantation 16 (9), 1293-1301, 2010 | 242 | 2010 |
| Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection G Gaipa, G Basso, O Maglia, V Leoni, A Faini, G Cazzaniga, C Bugarin, ... Leukemia 19 (1), 49-56, 2005 | 206 | 2005 |
| Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible MN Dworzak, G Gaipa, R Ratei, M Veltroni, A Schumich, O Maglia, ... Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2008 | 203 | 2008 |
| BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings P Lucio, G Gaipa, EG Van Lochem, ER Van Wering, A Porwit-MacDonald, ... Leukemia 15 (8), 1185-1192, 2001 | 202 | 2001 |
| CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy MN Dworzak, A Schumich, D Printz, U Pötschger, Z Husak, A Attarbaschi, ... Blood, The Journal of the American Society of Hematology 112 (10), 3982-3988, 2008 | 199 | 2008 |
| Genetic modification of human T cells with CD20: a strategy to purify and lyse transduced cells with anti-CD20 antibodies M Introna, AM Barbui, F Bambacioni, C Casati, G Gaipa, G Borleri, ... Human gene therapy 11 (4), 611-620, 2000 | 190 | 2000 |
| Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+ CD25+ GITR+ Foxp3+ CD62L+ functional regulatory T-cells in patients with graft-versus … E Biagi, I Di Biaso, V Leoni, G Gaipa, V Rossi, C Bugarin, G Renoldi, ... Transplantation 84 (1), 31-39, 2007 | 180 | 2007 |
| AIEOP‐BFM consensus guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia MN Dworzak, B Buldini, G Gaipa, R Ratei, O Hrusak, D Luria, E Rosenthal, ... Cytometry Part B: Clinical Cytometry 94 (1), 82-93, 2018 | 145 | 2018 |
| BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute … A Porwit-MacDonald, E Björklund, P Lucio, EG Van Lochem, J Mazur, ... Leukemia 14 (5), 816-825, 2000 | 143 | 2000 |
| CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease MN Dworzak, G Fröschl, D Printz, L De Zen, G Gaipa, R Ratei, G Basso, ... Leukemia 18 (4), 703-708, 2004 | 141 | 2004 |
| Detection of minimal residual disease in pediatric acute lymphoblastic leukemia G Gaipa, G Basso, A Biondi, D Campana Cytometry Part B: Clinical Cytometry 84 (6), 359-369, 2013 | 139 | 2013 |
| Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities CF Magnani, G Gaipa, F Lussana, D Belotti, G Gritti, S Napolitano, ... The Journal of clinical investigation 130 (11), 6021-6033, 2020 | 133 | 2020 |
| Recurrent ETNK1 mutations in atypical chronic myeloid leukemia CB Gambacorti-Passerini, C Donadoni, A Parmiani, A Pirola, S Redaelli, ... Blood, The Journal of the American Society of Hematology 125 (3), 499-503, 2015 | 128 | 2015 |
| Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse Z Good, J Sarno, A Jager, N Samusik, N Aghaeepour, EF Simonds, ... Nature medicine 24 (4), 474-483, 2018 | 120 | 2018 |
